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Chlorhexidine digluconate (CHX) is a gold standard drug in dentistry and is widely used as a reference 
in both in vitro and in vivo experiments. Due to ease of access, mouth washes containing CHX 0.12% are 
used as a substitute for aqueous CHX 0.12% solution in laboratory experiments. Additionally, it is well 
known that for product flavor purposes, volatile compounds are added to mouth washes formulations. 
Volatiles added to CHX 0.12% may improve wash’s antibacterial ability. Volatiles add potency to the 
mouth wash formulation. Compared with an aqueous CHX 0.12% solution, it is proposed that CHX 
solutions and Periogard® would have antimicrobial activity. Antimicrobial activity was assessed in 
the present study via disk diffusion assays against Streptococcus mutans, Streptococcus sanguinis and 
Escherichia coli. Periogard® showed a significantly higher antibacterial activity in relation to CHX 0.12% 
(p<0.05) and a similar activity in relation to CHX 1% (p>0.05). Periogard® volatiles were analyzed by 
gas-chromatography/mass spectrometry (GCMS) and the presence of antibacterial menthol, menthone, 
isomenthol, menthyl acetate, trans-anethol and eugenol was verified. Finally, the use of Periogard® as a 
synonym of CHX 0.12% must be avoided, because its antibacterial activity is closely related to CHX 1%.
Uniterms: Mouth washes/evaluation. Periogard®. Chlorhexidine. Antimicrobials/mouth use/evaluation.
Gluconato de clorexidina (CHX) é um fármaco considerado padrão ouro, em Odontologia, amplamente 
usado como referência em estudos in vitro e in vivo. Em razão da facilidade de acesso, enxaguatórios bucais 
que contêm CHX 0,12% são usados em substituição à solução aquosa de clorexidina (CHX 0,12%), em 
experimentos laboratoriais. É sabido que devido à palatabilidade do produto, os mesmos enxaguatórios 
bucais contêm compostos voláteis em sua formulação, além da CHX 0.12%. Visto que voláteis adicionados 
podem acrescentar poder antibacteriano à formulação, a comparação da resposta antibacteriana da solução 
aquosa de CHX em diferentes concentrações e de Periogard® é proposta no presente artigo. Para tanto, 
utilizou-se o ensaio do disco de difusão em ágar com inóculos de Streptococcus mutans, Streptococcus 
sanguinis e Escherichia coli. Periogard® mostrou atividade antibacteriana significativa contra as três 
cepas analisadas, quando comparada à atividade de CHX 0.12% (p<0,05) e atividade similar à CHX 
diluída a 1% (p>0,05). A presença de compostos voláteis no Periogard® foi analisada por GC-MS e 
observou-se que mentol, mentona, isomentol, acetato de mentila, trans-anetol e eugenol estão presentes 
na formulação. Deste modo, o uso de Periogard® como sinônimo de CHX 0,12% deve ser evitado, uma 
vez que sua atividade se assemelha àquela da CHX diluída a 1%.
Unitermos: Enxaguatórios bucais/avaliação. Periogard®. Clorexidina. Antimicrobianos/uso buccal/
avaliação.
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INTRODUCTION
Chlorhexidine digluconate (CHX) is considered a 
gold standard drug in dentistry (Van Strydonc et al., 2008; 
Barros et al., 1998) due to its extraordinary performance 
against several oral micro-organisms, despite some 
important side effects (Sivathasan et al., 2011). For this 
reason, CHX is frequently used in almost all in house 
antimicrobial in vitro and in vivo assays related to oral 
infectious diseases (Barros et al., 1998). CHX is also 
part of the composition of several mouth washes, such 
as Periogard®, and acts as the active agent. CHX has also 
been suggested to improve the performance and efficacy of 
mouth washes compared to washes that do not contain it. 
Periogard® is a mouth wash that is used worldwide, 
and according to the manufacturer, it is composed by 
CHX 0.12% and some inactive components, such as 
water, glycerin, ethanol, polysorbate 20, an aromatic 
composition with a predominant peppermint flavor, 
sodium saccharynate and FD&C Blue #1. 
Attention must be paid when using Periogard® as 
a standard drug in place of pure chlorhexidine solutions 
diluted in water, for laboratory or clinical experiments. The 
present work aims to compare the antimicrobial activity 
of 0.12%, 1% and 2% CHX, anfothericin B and nystatin 
to that of Periogard® against three micro-organisms that 
are commonly found in the mouth. The present work also 
claims that the effectiveness of Periogard® might be related 
to a synergy between chlorhexidine and the terpenes/
phenylpropanes that are present its formula.
MATERIAL AND METHODS
Drugs
CHX 2% was acquired (Fórmula & Ação, São 
Paulo, Brazil) and diluted with sterile distilled water to 
obtain both 0.12% and 1% dilutions. Solutions were kept 
in refrigeration until use.
Periogard® was acquired from a local drugstore, and 
was used in its original formula, without being diluted 
in water. The formula without ethanol was tested in the 
present work.
Bacteria preparation
A frozen vial (Coastar) containing Streptococcus 
mutans ATCC® 25175TM and Streptococcus sanguinis 
ATCC® 10556TM (both from Microbiologics) suspended in 
broth medium containing 30% dimethylsulfoxide (Tedia 
Brazil, Rio de Janeiro, Brazil) was thawed and 300 µL of 
the suspension was surface-seeded in Brain Heart Infusion 
agar Petri dishes to obtain a mother-plaque. Petri dishes 
(J. Prolab, São José dos Pinhais, Brazil) were kept in an 
incubator (Fanem, Diadema, Brazil) at 36 °C for 48 h. 
Then, mother-plaques presenting bacterial growth were 
kept in a refrigerator for up to one month. Fresh colonies 
were obtained weekly from the mother-plaque, and a 
sufficient amount of bacteria was collected from Petri 
dishes to prepare a suspension for further testing.
Escherichia coli ATCC® 25922TM Culti Loop® 
(Oxoid) was used to obtain mother-plaques by simply 
seeding a Müeller-Hinton agar Petri dish surface with 
lyophilized bacteria. The dish was kept in an incubator at 
36 °C for 24 h. Fresh colonies were obtained weekly from 
the mother-plaque, and a sufficient amount of bacteria was 
collected from Petri dishes with fresh colonies to prepare 
a suspension for further testing.
Medium
Brain Heart Infusion agar (Oxoid) and Müeller-
Hinton agar (Oxoid), used to test both Streptococci and 
Gram-negative bacteria, respectively. All media were 
prepared according to the manufacturer´s instruction 
(Oxoid) and were sterilized (Fanem) before use.
Antibacterial activity
Disk diffusion assay was performed according 
to CLSI (formely NCCLS) standards (8th edition, 
in Portuguese), with the following adaptations. A 
0.5 MacFarland saline suspension was prepared from 
a fresh colony of each micro-organism. The assay was 
performed in sterile Brain Heart Infusion agar for both 
Streptococci, in Müeller-Hinton agar for E. coli, and 
then prepared in Petri dishes (12 cm diameter). Sterile 
swabs (Deltalab, Beijing, China) were used to seed 
micro-organisms on the medium surface. Six paper disks 
(Cefar Diagnostico, Sao Paulo, Brazil) measuring 6 mm 
in diameter were distributed over the inoculated medium 
surface. Then, 10 µL of drugs were added to each disk, 
in triplicate. Disks were incubated at 36 °C for 48 h 
(for Streptococci) and 24 h (for E. coli). Following this 
procedure, the diameter of growth inhibition zones was 
measured both horizontally and vertically using a caliper 
rule (Digital Caliper, Beijing, China). 
Separation of the non polar content of Periogard®
A non-polar fraction was partitioned from non 
alcoholic Periogard®. Then, 100 mL of the mouth wash 
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was transferred to a 250 mL funnel, and 20 mL of hexane 
(HEX, Synth, Diadema, Brazil) was added to the system. 
The system was stirred and put to rest up to the separation 
of both phases. The HEX residue was transferred to a 
100 mL beaker. The operation was repeated two more 
times, and the HEX residues were combined in the 
beaker and left to evaporate. After that, the partition 
procedure was repeated with dichloromethane (DCM, 
Synth, Diadema, Brazil) with the remaining Periogard®. 
The DCM residue was evaporated, and no emulsion was 
formed. Residue samples were closed with a cap and 
kept in the freezer until use. Crystals were formed during 
the freezing period and were then isolated by filtration, 
diluted in the proper solvent and sent for analysis in a gas 
chromatography-mass spectrometer.
Gas chromatography-mass spectrometry analysis 
of non polar residues obtained from Periogard®
The HEX, DCM and MeOH residues were analyzed 
by a gas chromatographer (Shimatzu series 17A, Kyoto, 
Japan) coupled to a mass spectrometer (Shimatzu 
series QP5050A, Kyoto, Japan) (GC-MS). Non-polar 
residues were diluted in hexane or dichloromethane 
and injected into a gas chromatographer regulated 
to the following conditions: 1 µL of the sample was 
injected into a BPX5 column containing non-polar 5% 
phenylpolisylphenylene (30 m x 0.25 mm and a film 
of 0.25 µm); oven temperature of 60 °C; carrier gas 
of ultra-pure Helium at a flow of 2.5 mL/min; injector 
temperature of 280 °C; Mode Split; gradient starting 
at 60 °C (remaining for 2 min) increasing up to 320 °C 
(in 28 min) at a 10 °C/min rate and remaining at 320 °C 
for 6 min, totaling 34 min of development. The results 
relating to retention time 1 (7.82 min), retention time 3 
(8.03 min), retention time 4 (8.21 min), retention time 5 
(9.79 min), retention time 6 (9.91 min) and retention time 
7 (10.88 min) were in accordance with NIST® library.
Statistical analysis
Two-way ANOVA and Bonferroni’s post test were 
used to analyze the efficacy of the treatments against 
different micro-organisms. Statistically significance 
among means was considered if p<0.05. 
RESULTS
The results are shown in Figure 1. According to 
the two-way ANOVA analysis, both treatments and 
micro-organism’s parameters account for an extremely 
significance, as follows: treatments account for 45.31% 
of the total variance (F(3,60)=1092.39; p<0.0001), and 
micro-organisms accounts for 52.83% of the total 
variance (F(3,60)=1910.39; p<0.0001). Thus, CHX 0.12% 
did not show any antibacterial activity against E. coli, but 
did show activity against S. mutans (θ=14.01±0.78 mm) 
and somewhat less activity against S. sanguinis. CHX 
1% is significantly less active than CHX 2% (P<0.001) 
against both Streptococci and significantly less active 
against E. coli (p<0.05). If CHX 1% is compared with 
Periogard®, a significantly higher activity against S. 
mutans (p<0.001) and E. coli (p<0.01) is observed. CHX 
2% is significantly more active against S. mutans and S. 
sanguinis (p<0.001) than Periogard®, but it has a similar 
activity level against E. coli compared with Periogard® 
(p>0.05). 
This is the classification of chlorhexidine solutions 
and Periogard® in relation to their anti-Streptococci 
activity: CHX 2%>CHX 1%>Periogard®>CHX 0.12%. 
This is the classification of the standard drugs in 
relation to their anti-E. coli activity: CHX 1%> CHX 
2%=Periogard®> CHX 0.12%.
GC-MS analysis of HEX, DCM and MeOH residues 
showed the presence of the following volatiles: menthone 
(retention time 1), menthol (retention time 3), isomenthol 
(retention time 4), menthyl acetate (retention time 5), 
trans-anethol (retention time 6) and eugenol (retention 
time 7) (Figure 2).
FIGURE 1 - Disk diffusion assay (measurement of growth 
inhibition zones, in millimeters) for standard antimicrobial 
drugs and Periogard® against oral-occurring micro-organisms, 
analyzed by two-way ANOVA and Bonferroni’s post test 
(p<0.05). Statistically significant differences were found among 
CHX 0.12% x CH 1%, CHX2% and Periogard® (*); CHX1% x 
CHX2% (#); CHX1% x and Periogard® ($) and CHX2% x and 
Periogard® (&). CHX=chlorhexidine; Smut= Streptococcus 
mutans; Ssang= Streptococcus sanguinis; Ecoli= Escherichia 
coli.
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DISCUSSION
The use of CHX solutions as reference drugs is 
widespread in laboratories and in dental clinics. The 
antibacterial efficacy of each specific concentration 
permits CHX to be used as an active substance in 
varnishes, gels, and solutions and for a wide range of 
oral infection treatments, such as caries and dental 
plaque control (CHX 0.12%, 0.2% or 1%) (Berchier et 
al., 2010), mouth washes (CHX 0.2%) (SOLÍS et al., 
2011), periodontal pocket therapy (Vandekerckhove 
et al., 1996), gingivitis (Sheiham, 1997), plaque 
accumulation models (CHX 1%) (SLOT et al., 2010) 
and endodontitis and cavity preparation (CHX 2%) 
(Rôças, Siqueira, 2011; Gomes et al., 2009; Kontakiotis 
et al., 2008). A representative number of studies describe 
such benefits.
Periogard® is one of the most effective mouth 
washes recommended in dentistry, particularly due 
to the presence of CHX at concentration of 0.12%. 
Periogard® is commonly used as a standard drug (Barrella 
et al., 2012; Komiyama et al., 2010; Swaty et al., 2010; 
Botelho et al., 2009, Magalhães et al., 2009; Valera et 
al., 2009; Nascimento et al., 2008; Freitas et al., 2003) 
and as a synonym of 0.12% chlorhexidine digluconate. 
According to the manufacturer, Periogard® is a gluconate 
chlorhexidine solution that is prepared at a concentration 
of 0.12%, but its free alkali, or the molecule without 
the gluconate ion, which is the active compound in 
the formulae, is found at concentrations of 0.067% in 
Periogard® (Colgate-Palmolive, 2013). Thus, some 
authors use the concentration of 0.067% in their analysis 
(Felo et al., 1997). In the present manuscript, Periogard® 
containing 0.12% of chlorhexidine was used.
Although the antimicrobial activity of CHX and 
mouth washes has been described many times, studies 
reporting not only the antibacterial potency comparison 
between both CHX and Periogard®, but also the chemical 
composition analysis of Periogard®, are scarce. Because 
the misuse of CHX as synonym of Periogard® is frequent, 
the present work reports the results obtained from the 
comparison of the antibacterial analysis of CHX and 
Periogard®. The present work also describes the main 
volatiles extracted from the mouth wash to avoid a 
FIGURE 2 - Chromatogram obtained from gas chromatography of the non polar fractions obtained from Periogard®. The 
determination of structures was performed with a mass spectrometer, and the results were compared with the NIST® library as 
follows: menthone (retention time 1=7.82 min), menthol (retention time 3=8.03 min), isomenthol (retention time 4=8.21 min), 
menthyl acetate (retention time 5=9.79 min), trans anethol (retention time 6=9.91 min) and eugenol (retention time 7=10.88 min).
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misleading analysis of the results obtained from both in 
vivo and in vitro experiments.
Chlorhexidine solutions, as well as Periogard®, were 
tested against Streptococcus mutans and Streptococcus 
sanguinis, and against Escherichia coli. It was clearly 
observed that Periogard® had as much antibacterial 
activity as CHX 1%, and was significantly more active 
than CHX 0.12%. The presence of menthol, menthone, 
isomenthol, menthyl acetate, trans-anethol and eugenol 
may have added some antibacterial activity that might 
have influenced Periogard® efficacy because those 
terpenes/phenylpropanoids have previously shown 
antimicrobial activity (Li et al., 2011; Cetin et al., 2010; 
Lalli et al., 2010; Kotan et al., 2007; Savioli et al., 2006; 
Filoche et al., 2005; Harper et al., 2000).
CONCLUSIONS
According to the results obtained in the present work, 
all CHX solutions - except CHX 0.12% - and Periogard® 
showed antimicrobial activity, but Periogard® was as 
active as CHX 1%. This was perhaps due to the presence 
of the antibacterial active terpenes/phenylpropanoids 
menthol, menthone, isomenthol, menthyl acetate, trans- 
anethol and eugenol.
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